If you are a veterinarian operating a veterinary clinic, our products can enhance your treatment options. In particular, treatment of canine cancer is a particularly difficult prospect for most veterinarians. And many people with cancer-stricken dogs cannot afford the expense of a veterinary oncologist. Tumexal™ solves the problem that prevents you from using standard cytotoxic cancer chemo-therapy in your practice-- specifically, a confusing array of highly toxic and difficult to use drugs. Tumexal™ puts a new therapeutic tool into your hands: Monotherapy for canine cancer. Because of its novel mechanism of action-- the restoring of p53 tumor suppressor activity-- Tumexal™ is an extremely effective treatment option for virtually all forms of canine cancer. And because it is based on a new paradigm of cancer treatment, it controls cancer with virtually no toxicity. To call it a breakthrough in the treatment of canine cancer is no exaggeration. It is an effective treatment option that you can feel safe administering in your general practice; a treatment option that will stop the growth of almost any canine cancer, and will almost always produce rapid and dramatic improve-ments in the quality of life of your cancer-stricken canine patient. Tumexal™ is also effective as adjuvant therapy following surgery to address the problem of occult metastasis. We have data showing that Tumexal™ is extremely effective at preventing and/or eliminating such metastatic spread.
If you are a Veterinary Oncologist, you are undoubtedly faced with a percentage of owners who do not wish to put their dogs through the discomfort of cytotoxic chemo-therapy. Or you may have an animal that appears too lethargic or weak to be a good candidate for such chemotherapy. We urge you to try Tumexal™ in such cases. You will almost always see substantial improvement in mood, appetite and activity level in a treated dog, along with substantial reduction in cancer burden. Once the Tumexal™-treated dog has recovered strength, if you are not satisfied with the reduction in cancer burden that you observe with Tumexal™, you can proceed with your normal course of treatment in a more invigorated animal.
While the chemical composition of Tumexal™ is a protected trade secret of CanineCare.US, we will disclose it to licensed veterinarians who are considering its use in their practice. To obtain such disclosure, we require the signing of a standard confidentiality agreement. To receive our confidentiality agreement by email or fax, please contact: email@example.com
for cancer prevention
Preventil-7™ is a proprietary combination of seven plant flavanoids, each of which has proven ability to duplicate one or more of the actions of the p53 tumor suppressor pathway. (See Preventil-7™ page for chemical composition and details of mechanism of action.) Imagine what this means in terms of cancer prevention in pure breeds of dogs. As you know, most such pure breeds currently have about a 50% chance of dying of cancer; in Golden Retrievers this risk is 67% in males and 56% in females.* It is well known that p53 tumor suppressor activity is a critical determinant of cancer, because all cancers, both human and canine, have mutations in this pathway. By duplicating p53 tumor suppressor activity in high risk breeds, Preventil-7™ is poised to bring this excessive cancer risk under control. Towards this end, we hope you will consider Preventil-7™ for all of your high risk dog breeds. We also hope that you will join in the Golden Retriever Project which will, over the next decade, quantitate the effects of Preventil-7™ upon cancer risk in this and other high risk breeds.
lf you have any questions about Tumexal™, Preventil-7™, or any of our products, please call our specialist directly at 610-833-8136 (doc@CanineCare.us ) or use the form at right.
Licensed Veterinarians may request a PowerPoint presentation of Tumexal, which includes clinical data, using this form.